fashion -WSS

fashion

author：Wikipedia 2025-09-28 00:49:23 - browse：48

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： DeSantis wants to import drugs. Biden’s FDA blasted his plan

WSS

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Roche's accidental data boosts hopes for anti

New safety details link Apellis eye drug to rare cases of blindness

‘Oppenheimer’ and the risks of AI in health care

Adults seen as increasingly susceptible to measles

focus

fashion

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

PBMs are inflating the cost of generic drugs. They must be reined in

Continuity nursing helped my family in our darkest PICU moments

Intellia plays down concerns on accidental germline transmission

Wildfire smoke exposes gaps in outdoor worker protections

Breakthrough Alzheimer’s drugs are inaccessible in rural states

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How the drug

leisure time

California store owner shot dead in dispute over displaying Pride flag: Police

Adults seen as increasingly susceptible to measles

Abortion policy in the spotlight at Republican debate

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

EQRx, failed developer of low

FDA advisory panel to debate high blood pressure devices

knowledge

focus

entertainment

Wikipedia